CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Viridian Therapeutics›
Library
Viridian Therapeutics

Viridian Therapeutics

Viridian Therapeutics is a clinical-stage biopharmaceutical company developing IGF-1R therapies for thyroid eye disease.

Legal seat
Waltham, MA, US🇺🇸
Loading
Overview
Compare
Employees
Library

Viridian Therapeutics - Library

viridiantherapeutics.com·Crawled Oct 2, 2026·

Topics

Publication type

Content origin
Row density

Product

6 pages
  1. Expanded Access Policy/expanded-access-policy

    In certain circumstances, people living with a serious disease may gain access to an investigational medicine outside of clinical trials known as "Expanded Access" and sometimes also called "Pre-approval Access" or "Compassionate Use."

  2. Medicines/medicines
  3. Patients/patients

    We've worked hard to build a team that is passionate, caring, and dedicated to meeting the unique needs of the patient community we serve.

  4. Pipeline/pipeline

    We have created a robust pipeline of differentiated investigational therapeutic candidates for well-validated targets.

Blog

2 pages
  1. Post Single/post-single
  2. Scientific Presentations/pipeline/scientific-presentations

    Viridian strategically allocates research and development to address acute unmet medical patient needs; explore our scientific presentations today!

Press

2 pages
  1. Archive/newsroom/archive

    No press releases found for the selected year.

  2. Newsroom/newsroom

    For media or other general inquiries, please contact us using the form below.

Careers & Hiring

1 page
  1. Careers/careers

    Viridian celebrates individuality – valuing attitude, aptitude, and creativity as highly as skill.

Team

1 page
  1. Team/about/team

    Founding Partner, Fairmount Funds Management LLC

About

3 pages
  1. About/about

    The Viridian Therapeutics team’s expertise in antibody discovery & engineering, has created a robust pipeline of therapeutic candidates

  2. California Declaration of Comprehensive Compliance Program/about/california-declaration-of-comprehensive-compliance-program

    Viridian Therapeutics, Inc. (“Viridian”) is committed to conducting its business with integrity, transparency, and respect for healthcare professionals

  3. Compliance and Ethics/about/compliance-and-ethics

    At Viridian, we are committed to developing and delivering better medicines for people while conducting our business with integrity, accountability, and

Contact

1 page
  1. Contact/about/contact

    221 Crescent Street, Suite 103A Waltham, MA 02453

Homepage

1 page
  1. Homepage/

    Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions

Privacy

4 pages
  1. Cookie Policy/cookie-policy

    When you visit our website, it may store or retrieve information on your browser, mostly in the form of cookies. You can find out more about cookies and how

  2. Healthcare Professional Privacy Notice/hcp-privacy-notice

    Last Updated: February 27, 2026

  3. Privacy/privacy
  4. US Consumer Health Data Privacy Notices/us-consumer-privacy-notice

    Last Updated: April 7, 2026

Terms & Conditions

1 page
  1. Terms of Use/terms-of-use

    Date of Last Revision: April 7, 2026